Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant FOLFOX vs FL in Rectal Cancer
NCT00807911Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2008
- Primary completion
- Jun 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxaliplatin in rectal cancer, sponsored by Asan Medical Center. Primary endpoint: Disease-Free Survival at 3 years. Started Nov 2008; status: completed.
02
Drugs
oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00807911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807911.